Urological Malignancy Flashcards
Is the incidence of bladder carcinoma increasing or decreasing?
Decreasing
Who is more likely to get bladder cancer? Males or females?
Males
What ethnicity is at a higher risk of bladder cancer?
White
What risk factors are there for bladder cancer?
Smoking- 4* risk Occupational exposure (up to 20 years latent period): Rubber or plastics manafacture, handling of carbon, crude oil, combustion, painters, mechanics, printers, hairdressers
What is the histology of bladder cancer?
Transitional cell carcinoma
20% are squamous cell carcinoma
What are the risk factors for developing squamous cell carcinoma of the bladder>
Long term catheters, recurrent UTIs, bladder stones
Schistosomiasis in endemic areas
What are the treatment options for bladder cancer?
Initial assessment- TURBT- transurethral resection, allows assessment of histological type, grade and stage. If tumour is superficial, a single dose of intravesical mytomycin is given
Low risk, non muscle invasive- check cystoscopies
Intermediate/ high risk-intravesicular chemotherapy/ BCG
Muscle invasive- either neoadjuvant chmmo and radical cystectomy with formation of ileal conduit or palliative chemo
Metastatic- palliative systemic chemotherapy or biological therapies- PDL1 inhibitors
What percentage of upper urinary tract tumours does Renal cell carcinoma make up?
95%
Is the incidence of renal cell carcinomas increasing or decreasing?
Increasing
Who is most likely to get renal cell carcinoma?
White males
What are the risk factors for renal cell carcinoma?
Heavy smoking, obesity, positive family history
What is the histology of renal cell carcinoma?
Its an adenocarcinoma, can be either clear cell- commonest, papillary, chromophobe, collecting duct (Von hippel Lindau) or medullary- sickle cell anaemia
What percentage of patients have mets on presentation with renal cell carcinoma?
30%
How does renal cell carcinoma present?
Haematuria
Incidental finding
Palpable mass- rare
What are the treatment options for renal cell carcinoma?
ablation, surveillance, partial nephrectomy, radical nephrectomy
Tyrosine kinase inhibitors can be given if metastatic